➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Moodys
Harvard Business School
Express Scripts
Baxter

Last Updated: July 3, 2020

DrugPatentWatch Database Preview

Patent Applications for SUTENT


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

US Patent Applications for SUTENT

US Patent Application Patent No. Title Patent Filing Date Patent Application Status Status Updated
  Start Trial   Start Trial METHODS OF MODULATING C-KIT TYROSINE PROTEIN KINASE FUNCTION WITH INDOLINONE COMPOUNDS 2000-12-22 Abandoned -- Failure to Pay Issue Fee 2003-07-23
  Start Trial   Start Trial MANNICH BASE PRODRUGS OF 3-(PYRROL-2-YLMETHYLIDENE)-2-INDOLINONE DERIVATIVES 2001-05-24 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 2008-04-21
  Start Trial   Start Trial PYRROLE SUBSTITUTED 2-INDOLINONE PROTEIN KINASE INHIBITORS 2001-02-15 Patented Case 2003-05-14
  Start Trial   Start Trial Crystals including a malic acid salt of a 3-pyrrole substituted 2-indolinone, and compositions thereof 2002-08-13 Abandoned -- Failure to Respond to an Office Action 2007-08-29
  Start Trial   Start Trial PRODRUGS OF A 3-(PYRROL-2-YLMETHYLIDENE)-2-INDOLINONE DERIVATIVES 2002-04-09 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 2008-10-27
  Start Trial   Start Trial Treatment of acute myeloid leukemia with indolinone compounds 2002-10-28 Abandoned -- Failure to Respond to an Office Action 2006-02-04
  Start Trial   Start Trial INDOLINONE PROTEIN KINASE INHIBITORS AND CYCLOOXYGENASE INHIBITORS FOR USE IN COMBINATION THERAPY FOR THE TREATMENT OF CANCER 2002-08-15 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 2012-02-20
>US Patent Application >Patent No. >Title >Patent Filing Date >Patent Application Status >Status Updated

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Harvard Business School
McKesson
Medtronic
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.